Frequency of Atrial Arrhythmia in Hospitalized Patients With COVID-19

[1]  S. Markowitz,et al.  Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID‐19 , 2020, Journal of cardiovascular electrophysiology.

[2]  P. Navalesi,et al.  Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit , 2020, Thrombosis and Haemostasis.

[3]  N. M. Hettiarachchi,et al.  Clinical Characteristics of COVID-19 , 2020, Journal of the Ceylon College of Physicians.

[4]  B. Abella,et al.  COVID-19 and cardiac arrhythmias , 2020, Heart Rhythm.

[5]  Nathaniel Hupert,et al.  Clinical Characteristics of Covid-19 in New York City , 2020, The New England journal of medicine.

[6]  I. Hysi,et al.  Severe Acute Proximal Pulmonary Embolism and COVID-19: A Word of Caution , 2020, The Annals of Thoracic Surgery.

[7]  Lei Liu,et al.  First case of COVID-19 complicated with fulminant myocarditis: a case report and insights , 2020, Infection.

[8]  Juan Du,et al.  Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study , 2020, European Respiratory Journal.

[9]  Marc A Pfeffer,et al.  Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 , 2020, The New England journal of medicine.

[10]  Tao Guo,et al.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[11]  D. Brodie,et al.  The Variety of Cardiovascular Presentations of COVID-19 , 2020, Circulation.

[12]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[13]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[14]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[15]  Catharine I Paules,et al.  Coronavirus Infections-More Than Just the Common Cold. , 2020, JAMA.

[16]  T. Kuribayashi.  Elimination half-lives of interleukin-6 and cytokine-induced neutrophil chemoattractant-1 synthesized in response to inflammatory stimulation in rats , 2018, Laboratory animal research.

[17]  D. D. de Lange,et al.  The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years) , 2017, Intensive Care Medicine.

[18]  T. Chao,et al.  The association between influenza infection, vaccination, and atrial fibrillation: A nationwide case-control study. , 2016, Heart rhythm.

[19]  S. Klein,et al.  SeXX Matters in Infectious Disease Pathogenesis , 2016, PLoS pathogens.

[20]  E. Benjamin,et al.  New-onset atrial fibrillation during hospitalization. , 2014, Journal of the American College of Cardiology.

[21]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[22]  D. Kamat,et al.  Erythrocyte sedimentation rate and C-reactive protein: how best to use them in clinical practice. , 2014, Pediatric annals.

[23]  R. Albert,et al.  Macrolide antibiotics and the risk of cardiac arrhythmias. , 2014, American journal of respiratory and critical care medicine.

[24]  J. Alexander,et al.  Cardiovascular risks with azithromycin and other antibacterial drugs. , 2013, The New England journal of medicine.

[25]  S. Yusuf,et al.  Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials. , 2013, International journal of cardiology.

[26]  G. Lip,et al.  Inflammation in atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[27]  F. Jaimes,et al.  D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. , 2012, The American journal of emergency medicine.

[28]  C Michael Stein,et al.  Azithromycin and the risk of cardiovascular death. , 2012, The New England journal of medicine.

[29]  E. Fish,et al.  Sex affects immunity. , 2012, Journal of autoimmunity.

[30]  S. Iravanian,et al.  Inhibition of renin-angiotensin system (RAS) reduces ventricular tachycardia risk by altering connexin43 , 2011, Journal of Molecular Medicine.

[31]  W. Baker,et al.  Azithromycin for the secondary prevention of coronary artery disease: a meta-analysis. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[32]  S. Opal,et al.  Coagulation in sepsis , 2004, Intensive Care Medicine.

[33]  J. Luban.  SARS-CoV-2 , 2020 .

[34]  Jennifer G. Robinson,et al.  ACCF/AHA TASK FORCE MEMBERS , 2013 .